William G. Nelson

Last updated
William G. Nelson
NationalityAmerican
Alma mater Yale University, Johns Hopkins University
Known forProstate Cancer
Scientific career
Fields Urology
Oncology
Institutions Johns Hopkins University
Website William Nelson

William G. Nelson is the Marion I. Knott Professor of Oncology, Urology, Pharmacology, Pathology, and Medicine at the Johns Hopkins School of Medicine. He earned his B.A. in Chemistry from Yale University in 1980 and his M.D. and Ph.D. in Pharmacology from Johns Hopkins School of Medicine in 1987. His research is focused on cancer epigenetics and on new strategies for prostate cancer and prevention. He serves on the boards of the V Foundation, the Break Through Cancer Foundation, and Armis Biopharma, and on the scientific advisory boards of the Prostate Cancer Foundation, Stand Up to Cancer, and Cepheid. [1] [2] [3] He was appointed as the Director of the Sidney Kimmel Comprehensive Cancer Center in 2008. [4]

Related Research Articles

<span class="mw-page-title-main">Johns Hopkins University</span> Private university in Baltimore, Maryland

Johns Hopkins University is a private research university in Baltimore, Maryland. Founded in 1876, Johns Hopkins was the first U.S. university based on the European research institution model.

<span class="mw-page-title-main">Vincent T. DeVita</span> American oncologist and academic

Vincent Theodore DeVita Jr. is the Amy and Joseph Perella Professor of Medicine at Yale Cancer Center, and a Professor of Epidemiology and Public Health. He directed the Yale Cancer Center from 1993 to 2003. He has been president of the American Cancer Society (2012-2013). He is internationally recognized as a pioneer in the field of oncology for his work on combination-chemotherapy treatments.

Samuel Ray Denmeade is a Professor of Oncology, Urology and Pharmacology and Molecular Sciences at the Johns Hopkins University School of Medicine. Over 10 of his published papers have each been cited over 100 times.

<span class="mw-page-title-main">Elias Zerhouni</span>

Elias Zerhouni is an Algerian-born American scientist, radiologist and biomedical engineer.

<span class="mw-page-title-main">William H. Welch</span> American physician (1850–1934)

William Henry Welch was an American physician, pathologist, bacteriologist, and medical-school administrator. He was one of the "Big Four" founding professors at the Johns Hopkins Hospital. He was the first dean of the Johns Hopkins School of Medicine and was also the founder of the Johns Hopkins School of Hygiene and Public Health, the first school of public health in the country. Welch was more known for his cogent summations of current scientific work, than his own scientific research. The Johns Hopkins medical school library is also named after Welch. In his lifetime, he was called the "Dean of American Medicine" and received various awards and honors throughout his lifetime and posthumously.

M. Krishnan Nair was an Indian oncologist. He was the founding director of the Regional Cancer Centre, Thiruvananthapuram, a director of the S.U.T. Institute of Oncology, and Trivandrum Cancer Center(TCC), part of SUT Royal Hospital in Thiruvananthapuram (Trivandrum) and a professor at the Amrita Institute of Medical Sciences & Research in Kochi. The Government of India awarded him the fourth highest civilian award of the Padma Shri in 2001 for his contributions in the cancer care field.

Early prostate cancer antigen-2 (EPCA-2) is a protein of which blood levels are elevated in prostate cancer. It appears to provide more accuracy in identifying early prostate cancer than the standard prostate cancer marker, PSA.

<span class="mw-page-title-main">Jonathan Simons</span> American oncologist

Jonathan W. Simons is an American physician-scientist, medical oncologist, and leader in prostate cancer research. In August 2021, Simons was appointed the medical director and Chief Science Officer of the Marcus Foundation. Prior to joining the Marcus Foundation, he served a 14-year tenure as the President and chief executive officer of the Prostate Cancer Foundation. Simons’ laboratories, partly funded by the Prostate Cancer Foundation, at Johns Hopkins University and Emory University made original contributions to understanding the molecular biology of prostate cancer metastasis and principles of “broken immune tolerance” via T cell based immunotherapy for prostate cancer. The Simons lab invented GM-CSF genetically engineered vaccines for prostate cancer in rodents and humans for these studies, and subsequently Simons’ clinical team took the biotechnology into the world’s first human gene therapy clinical trials for advanced prostate cancer at Johns Hopkins.

William Douglas Figg is an American scientist (pharmacologist). He is a senior investigator (tenured) at the National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, Maryland. He holds multiple titles within the NCI: Associate Director of the Center for Cancer Research, Co-Director of the Office of Translational Resources, Acting Branch Chief for the Genitourinary Malignancies Branch, Chief of the Clinical Pharmacology Program, and head of the Molecular Pharmacology Section. Dr. Figg is also the Co-Chief of Basic Research at the Center for Prostate Disease Research within the Walter Reed National Military Medical Center – Murtha Cancer Center in Bethesda, Maryland.

<span class="mw-page-title-main">Denis Wirtz</span> Belgian molecular biologist (born 1965)

Denis Wirtz is the vice provost for research and Theophilus Halley Smoot Professor of Engineering Science at Johns Hopkins University. He is an expert in the molecular and biophysical mechanisms of cell motility and adhesion and nuclear dynamics in health and disease.

<span class="mw-page-title-main">William Kaelin Jr.</span> American Nobel Laureate, Professor of Medicine at Harvard University

William G. Kaelin Jr. is an American Nobel laureate physician-scientist. He is a professor of medicine at Harvard University and the Dana–Farber Cancer Institute. His laboratory studies tumor suppressor proteins. In 2016, Kaelin received the Albert Lasker Award for Basic Medical Research and the AACR Princess Takamatsu Award. He also won the Nobel Prize in Physiology or Medicine in 2019 along with Peter J. Ratcliffe and Gregg L. Semenza.

Kenneth C. Anderson is an American hematologist-oncologist and cancer researcher who is primarily known for advances in the treatment of multiple myeloma. He directs the Lebow Institute for Myeloma Therapeutics and Jerome Lipper Myeloma Center at Dana–Farber Cancer Institute and is the Kraft Family Professor of Medicine and Vice Chair of the Joint Program in Transfusion Medicine at Harvard Medical School.

The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University is an NCI-Designated Comprehensive Cancer Center in Baltimore, MD. It was established in 1973 and received its NCI designation that same year as one of the first designated cancer centers in the country.

Donald Straley Coffey was the Catherine Iola and J. Smith Michael distinguished professor of urology at Johns Hopkins University School of Medicine and subsequently professor emeritus. He had a primary appointment in urology and secondary appointments in oncology, pharmacology and pathology.

<span class="mw-page-title-main">Kenneth J. Pienta</span>

Kenneth J. Pienta is a medical doctor and the Donald S. Coffey professor of urology and professor of oncology and pharmacology and molecular sciences at the Johns Hopkins University School of Medicine. He also serves as the director of research at the Brady Urological Institute.

<span class="mw-page-title-main">Elizabeth Jaffee</span> American oncologist

Elizabeth M. Jaffee is an American oncologist specializing in pancreatic cancer and immunotherapy.

Ashani Tanuja Weeraratna is a Sri Lanka-born American cancer researcher whose findings are contributing to the scientific understanding of melanoma tumors. She is a Bloomberg Distinguished Professor of cancer biology and the E.V. McCollum Professor and Chair of the department of biochemistry and molecular biology at the Johns Hopkins Bloomberg School of Public Health. Weeraratna is a member of the National Cancer Advisory Board, which advises and assists the director of the National Cancer Institute on the activities of the national cancer program.

Patrick C. Walsh is an American urologist, researcher and writer, best known for developing "the anatomic approach to radical prostatectomy", involving nerve-sparing techniques which reduced the likelihood of impotence and urinary incontinence. He authored The Prostate: A Guide for Men and the Women Who Love Them and Dr. Patrick Walsh's Guide to Surviving Prostate Cancer.

Alan Wayne Partin was an American prostate surgeon and researcher. He was the Jakurski Family Director of the Brady Urological Institute, Urologist-In-Chief of Johns Hopkins School of Medicine, and professor of Urology, Pathology, and Oncology. In 1993, he developed the PartinTables to help prostate cancer patients get an accurate prediction of their likelihood of being cured.

Julie Renee Brahmer is an American thoracic oncologist. She is the Co-Director of the Upper Aerodigestive Department within the Bloomberg~Kimmel Institute for Cancer Immunotherapy at Johns Hopkins University and the Marilyn Meyerhoff Professor in Thoracic Oncology.

References

  1. "William G. Nelson". JHU. Retrieved 13 January 2016.
  2. "Stand Up To Cancer — Scientific Advisory Committee — Biographies". Stand Up To Cancer. Retrieved 13 January 2016.
  3. "Dr. William G. Nelson Is New Editor-in-Chief - Cancer Today". www.cancertodaymag.org. Cancer Today. 26 February 2015. Retrieved 13 January 2016.
  4. "Prostate Cancer Specialist William Nelson to Head Cancer Center". pages.jh.edu. Johns Hopkins Gazette. 10 November 2008. Retrieved 13 January 2016.